Provider P12-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization for Minnesota Health Care Programs Read More
Provider QP5-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sucraid® (sacrosidase) PAQL Read More
Provider QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021 Read More
Provider QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric® Read More
